Volume-Oriented Incentive Spirometry-Assisted Diaphragmatic Breathing Exercise for Functional Heartburn or Reflux Hypersensitivity
NCT07706101 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 82
Last updated 2026-07-15
Summary
The goal of this pilot randomized controlled trial is to determine whether volume-oriented incentive spirometry-assisted diaphragmatic breathing exercise (VIS-assisted DBE) can improve reflux-related symptoms and health-related quality of life in adults with functional heartburn (FH) or reflux hypersensitivity (RH).
The main questions it aims to answer are:
Does VIS-assisted DBE reduce reflux-related symptoms compared with usual care? Does VIS-assisted DBE improve health-related quality of life compared with usual care? Researchers will compare VIS-assisted DBE plus usual care with usual care alone to determine whether the intervention provides additional benefits in symptom relief and quality of life.
Participants will:
Complete baseline clinical evaluations and symptom questionnaires. Be randomly assigned to either the VIS-assisted DBE group or the usual care group.
Receive either VIS-assisted diaphragmatic breathing exercises twice daily for 20 minutes over a 4-week period in addition to usual care, or usual care alone.
Complete follow-up assessments after the 4-week intervention, including symptom and quality-of-life questionnaires
Conditions
- Functional Heartburn (FH)
- Reflux Hypersensitivity
Interventions
- BEHAVIORAL
-
Volume-Oriented Incentive Spirometry-Assisted Diaphragmatic Breathing Exercise
Participants will perform diaphragmatic breathing exercises assisted by a volume-oriented incentive spirometer twice daily for 20 minutes per session over a 4-week intervention period under standardized instructions.
- BEHAVIORAL
-
standard pharmacological treatment with lifestyle modification education
Participants will receive standard pharmacological treatment and lifestyle modification education without structured diaphragmatic breathing exercise.
Sponsors & Collaborators
-
Changhua Christian Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-20
- Primary Completion
- 2028-04-30
- Completion
- 2028-07-30
More Related Trials
-
Predictive Value of Subjective and Objective Measurement Tools for Extraesophageal Reflux
NCT01829074 ·Status: UNKNOWN
-
Mobile Application for Gastroesophageal Reflux Disease
NCT07744815 ·Status: COMPLETED ·Phase: NA
-
Effect of Acid Reflux on Respiratory Physiology During Exercise in Athletes With GER-Response to Acid Suppression
NCT00444236 ·Status: TERMINATED ·Phase: PHASE1
-
A Retrospective Analysis of Patients With Gastroesophageal Reflux Disease Based on a Prospective Clinical Dataset
NCT07749989 ·Status: RECRUITING
-
Method of Early Diagnosis of Laryngopharyngeal Reflux
NCT04771221 ·Status: COMPLETED ·Phase: NA
-
Individualized Diagnosis and Treatment of Extraesophageal Reflux in Patients With Chronic Cough
NCT04984304 ·Status: RECRUITING ·Phase: NA
-
Potassium Competitive Acid Blocker (PCAB) Test-Guided vs Physiologic Test-Guided Treatment in Patients With Typical Reflux Symptoms
NCT07707011 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Response to Supplement and Placebo in GERD
NCT01915173 ·Status: COMPLETED ·Phase: NA
-
Effects of Clinical Pilates Exercises on Symptoms, Posture, Balance and Quality of Life in GERD
NCT07573280 ·Status: COMPLETED ·Phase: NA
-
Symptom Severity, Posture, Pain, and Physical Activity in Gastroesophageal Reflux Disease
NCT07643779 ·Status: NOT_YET_RECRUITING
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Study of an Oropharyngeal Aerosolized pH Probe for Diagnosing Laryngopharyngeal Reflux (LPR)
NCT00321503 ·Status: COMPLETED
-
Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.
NCT00786773 ·Status: COMPLETED
-
Mechanisms Preventing Pharyngeal Reflux
NCT05696184 ·Status: RECRUITING ·Phase: NA
-
RESULT (REflux Surgery in Lung Transplantation) Preliminary Study Protocol
NCT01406210 ·Status: COMPLETED
-
Effect of Extraesophageal Reflux on Inferior Nasal Turbinates Hypertrophy
NCT04581174 ·Status: COMPLETED ·Phase: NA
-
Positive Predictive Value of the Dx-pH Probe for Predicting PPI Response in LPR
NCT01755221 ·Status: COMPLETED
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Patient Education in Gastroesophageal Reflux Disease
NCT00618150 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Study of Children With a Chronic Cough and the Impact of Gastroesophageal Reflux
NCT00771706 ·Status: WITHDRAWN ·Phase: PHASE3
-
"The Voice of Reflux" - Backflow of Gastric Juice Leads to Irritation of the Vocal Folds: Are There Typical Differences in the Voice?
NCT06495606 ·Status: RECRUITING
-
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Non Erosive Reflux Disease
NCT03811080 ·Status: UNKNOWN ·Phase: PHASE3
-
A Multi-center, Randomized, Double-blind, Parallel-group, Placebo Controlled Phase III Study to Evaluate the Efficacy and Safety of LXI-15028 in Non-erosive Reflux Disease in Chinese Patients for 4 Weeks
NCT03591653 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
NCT01574573 ·Status: TERMINATED ·Phase: NA
-
The Effect of Esomeprazole and Fundoplication on Airways
NCT00994708 ·Status: COMPLETED ·Phase: PHASE3